ArticleFrontiers in pediatrics2026

Real-world effectiveness and safety of dupilumab therapy in children ≤6 years with uncontrolled persistent asthma: a propensity-matched retrospective cohort study.

Ahlam Mazi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.